Skip to main content
Equibles

HighTower Advisors, LLC

Position in VTGN — Vistagen Therapeutics, Inc.

CIK 1462245 CHICAGO, IL
Back to VTGN Full portfolio

Position in VTGN

as of Jun 30, 2026 · filed Aug 5, 2026
Position Value
$4,744
-$7,013 QoQ
Shares Held
20,628
0.0% QoQ
Ownership
0.046%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#30
of 48 holders
Holding Since
Mar 2020
20 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VTGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

HighTower Advisors, LLC holds $312,855,129 across 115 Biotechnology names. VTGN ranks #114 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 INBX
Inhibrx Biosciences, Inc.
 870,551 $82,484,707
2 REGN
Regeneron Pharmaceuticals, Inc.
 64,650 $40,311,861
3 ALNY
Alnylam Pharmaceuticals, Inc.
 105,045 $31,621,696
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 49,020 $24,349,704
5 RPRX
Royalty Pharma plc
 285,630 $16,015,274
6 EXEL
Exelixis, Inc.
 291,162 $15,842,124
7 AXSM
Axsome Therapeutics, Inc.
 56,313 $13,783,733
8 ARWR
Arrowhead Pharmaceuticals, Inc.
 140,394 $11,443,514

All Filings in VTGN

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,744 20,628
2026-03-31 $11,757 20,628
2025-12-31 $13,614 20,628
2025-09-30 $73,939 20,828
2025-06-30 $41,656 20,828
2025-03-31 $52,070 20,828
2024-12-31 $61,442 20,828
2024-09-30 $62,692 20,828
2023-03-31 $14,552 121,273
2022-12-31 $12,127 121,273
2022-09-30 $23,590 157,273
2022-06-30 $142,628 162,078
2022-03-31 $200,976 162,078
2021-12-31 $265,352 136,078
2021-09-30 $372,853 136,078
2021-06-30 $428,645 136,078
2021-03-31 $268,546 126,078
2020-09-30 $92,629 132,328
2020-06-30 $70,133 132,328
2020-03-31 $58,224 132,328